Ajanta Pharma Limited

NSE AJANTPHARM.NS

Ajanta Pharma Limited Price to Sales Ratio (P/S) on February 07, 2025: 7.61

Ajanta Pharma Limited Price to Sales Ratio (P/S) is 7.61 on February 07, 2025, a 1.49% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Ajanta Pharma Limited 52-week high Price to Sales Ratio (P/S) is 10.14 on September 10, 2024, which is 33.24% above the current Price to Sales Ratio (P/S).
Ajanta Pharma Limited 52-week low Price to Sales Ratio (P/S) is 6.14 on April 16, 2024, which is -19.33% below the current Price to Sales Ratio (P/S).
Ajanta Pharma Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 7.93.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: AJANTPHARM.NS

Ajanta Pharma Limited

CEO	Mr. Yogesh Mannalal Agrawal M.B.A
IPO Date	July 1, 2002
Location	India
Headquarters	Ajanta House
Employees	8,073
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care

Description

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.

Key trends

Past 5 years